Common questions about Fluoresceina (FAQ)
Q: Is Fluoresceina dye the same thing as a regular eye drop?
Fluorescein is classified as a diagnostic agent, not a therapeutic drug intended to treat or cure a disease like a regular eye drop. Official product information states its sole purpose is to act as a colorant and contrast agent to help healthcare providers visualize specific tissues during an examination.
Q: Does Fluoresceina hurt when it's put in the eye?
When used as topical drops or strips, common adverse events reported include temporary stinging, burning, and redness of the eye. If the intravenous injection leaks out of the vein (extravasation), it can cause pain and tissue damage at the injection site.
Q: How quickly does Fluoresceina start to work after the drops are applied?
When the topical strips are applied to the eye, the effect appears immediately upon contact with the tear film. Regulatory guidance often advises that the patient blink several times to ensure that the dye is fully distributed for the examination.
Q: How long does the full effect of Fluoresceina last when injected for an angiogram?
Following an intravenous injection, the luminescent effect typically appears in the retinal and choroidal vessels within 7 to 14 seconds. The temporary yellow discoloration of the skin, which is a common side effect, is typically expected to fade within 6 to 12 hours as the drug is cleared from the system.
Q: Is Fluoresceina safe for pregnant women needing an eye exam?
The FDA classifies Fluorescein as Pregnancy Category C. Regulatory classification indicates it is used during pregnancy only if the potential benefit justifies the potential risk to the fetus, as human safety data is limited and animal studies have not been adequate to determine fetal harm.
Q: Can Fluoresceina dye stain my clothes or contact lenses permanently?
Official warnings state that soft contact lenses must be removed prior to topical use to prevent staining. The temporary yellowish skin and urine discoloration that occur after an intravenous injection are expected and generally fade within 12 to 36 hours as the dye is eliminated from the body.
Q: Can people with kidney problems use Fluoresceina safely?
Patients with severe renal impairment, such as those undergoing dialysis, may require a reduced dose because the drug is cleared more slowly. Official information notes a long history of use. However, caution is advised, and the determination of suitability and dose adjustment is made by the healthcare provider.
Q: Does having diabetes change how Fluoresceina is used or affects me?
Clinical literature indicates that patients with both diabetes and kidney impairment might experience higher plasma concentrations and slower clearance of the dye than healthy individuals. Healthcare providers take this into account during administration of the injection.
Q: Is it normal if my eye feels a little scratchy right after the Fluoresceina drops?
Official regulatory documents list stinging, burning, and eye irritation as common ocular adverse events when the drops are used topically. These effects are generally described as temporary.
Q: What are the main risks of getting a Fluoresceina injection?
The main risks associated with the intravenous injection route include the potential for severe local tissue damage if the solution leaks out of the vein (extravasation). Other serious, though rare, risks include respiratory reactions like bronchospasm, and severe hypersensitivity reactions, such as anaphylaxis or cardiac arrest.
Q: Can Fluoresceina be used to check for contact lens problems?
Yes, the ophthalmic strips are officially indicated for staining the eye’s anterior segment. This includes assisting in the proper fitting of contact lenses, as the dye helps to highlight pressure points or areas of insufficient tear film.
Q: Does Fluoresceina interact with any common over-the-counter pain relievers?
The drug's systemic clearance can be affected by compounds that compete with the active transport of organic anions, such as probenecid. Additionally, the fluorescence of the dye can temporarily interfere with certain laboratory tests of blood and urine for up to four days after administration.
Q: Why do doctors use an injection instead of just drops sometimes?
The choice of route is determined by the diagnostic need. The injection is used for angiography to visualize internal structures and blood flow in the retina and iris. In contrast, the drops or strips are strictly for the topical staining of the external surfaces of the eye, such as the cornea.
Q: How does the doctor monitor for an allergic reaction to Fluoresceina?
Official warnings require that an emergency tray with appropriate resuscitation materials, such as adrenaline, be readily available during administration. This is a regulatory requirement to allow for rapid intervention if a serious hypersensitivity reaction were to occur.
Q: Why do patients need to fast before a Fluoresceina angiogram?
Nausea, vomiting, and general gastrointestinal distress are common adverse events reported following the intravenous injection. Although fasting is not a universal regulatory requirement, it may be recommended by the clinical site due to the drug's side effect profile.
Q: Is Fluoresceina used to check the health of the front part of the eye, like the cornea?
Yes. The ophthalmic strip is specifically indicated for staining the anterior segment of the eye, which helps to disclose and check for injuries or abrasions on the cornea.
Q: Is it true that Fluoresceina is derived from a natural substance?
No. Fluorescein sodium is chemically defined as a synthetic Xanthene Dye, meaning it is a compound created in a laboratory and is not derived from a natural source.
Q: Why is this test sometimes called 'fluorescein angiography'?
The test is called angiography because it is a method of visualization (graphy) of the blood vessels (angio). It uses the fluorescent dye (fluorescein) to enhance the contrast and make the blood flow visible to the specialized camera.
Q: What is the shelf life of an open bottle of Fluoresceina drops in a clinic?
Regulatory guidance for the ophthalmic solutions specifies that single-use vials or strips must be discarded immediately after opening. Any unused portion of the product must also be properly discarded according to local requirements.
